PTK2 and neoplasm: By combining pharmacological inhibition and genetic silencing, we aimed to evaluate the effects of FAK disruption on GI-NET cell viability, apoptosis, invasiveness, and transcriptional regulation, and to assess its potential as a therapeutic target in this challenging tumor type.